Debt-to-equity of Pyxis Oncology, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pyxis Oncology, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Pyxis Oncology, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 37%, a 44% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Pyxis Oncology, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 37% +11% +44% 30 Sep 2025
Q2 2025 31% +3.7% +13% 30 Jun 2025
Q1 2025 27% -0.15% -0.55% 31 Mar 2025
Q4 2024 24% -3.7% -13% 31 Dec 2024
Q3 2024 26% -0.87% -3.2% 30 Sep 2024
Q2 2024 28% +5.2% +23% 30 Jun 2024
Q1 2024 27% +6.9% +33% 31 Mar 2024
Q4 2023 28% +11% +65% 31 Dec 2023
Q3 2023 27% +15% +132% 30 Sep 2023
Q2 2023 23% +9.2% +68% 30 Jun 2023
Q1 2023 21% 31 Mar 2023
Q4 2022 17% 31 Dec 2022
Q3 2022 12% 30 Sep 2022
Q2 2022 13% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.